💊Why dual-target #CB1R and iNOS inhibition by #MRI1867 (#zevaquenabant) is an emerging clinical candidate for #PulmonaryFibrosis #CureIPF ❗️Please visit to learn tonight Poster# 1010 presented by Dr Abhishek Basu Abhishek Basu #KSfibrosis23 #KeystoneFibrosis2023 👇

Check out our major update to Alcohol Facts and Statistics! The expanded content is now presented on separate web pages for improved readability and navigability. Topics include alcohol use, related consequences, and more. #NDAFW fal.cn/3wMyN

🥃 🫁Why lungs are more sensitive for immune dysregulation than liver with heavy alcohol drinking? ❗️Please visit to learn tonight Poster # 3013 presented by Dr Lenny Pommerolle @pommerollelenny #KSfibrosis23 #KeystoneFibrosis2023 👇

⏳Giving a short afternoon break to #KSFibrosis23 #KeystoneFibrosis2023 with learning outdoor E.C.M. activities in nature #Banff #Lakelouise ✨Extra Cellular Matrix produced by algea and fungi on Spruce 🌲 trees. ❄️🌈Enjoying snow Covered Mountains. @pommerollelenny

New Research: Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy frontiersin.org/articles/10.33… #Nephrology

Happy to share our newest piece of work. Another step towards the come back of CB1R blockers! Thanks to Inversago Pharma for trusting us on that one. #cannabinoids#nephropathy

Excited to attend my first Hermansky-Pudlak Syndrome (HPS) Network Conference. I will be presenting our work on HPS Pulmonary Fibrosis progressive biomarkers using data-driven and multi-omics network analysis. #hpsnetwork

After 4 years, finally this weekend 45 scientists and clinicians meet again in-person HPS Network Meeting to discuss exciting science all about #HermanskyPudlakSyndrome and how to #CureHPS HPSNetwork

Our research NIAAA News published @AdvSciNews “An Integrative Multiomics Framework for Identification of Therapeutic Targets in #pulmonaryfibrosis” onlinelibrary.wiley.com/doi/10.1002/ad… #cureIPF #curePF

Presenting how inhalation delivery of MRI-1867 (zevaquenabant) can be a better therapeutic modality in pulmonary fibrosis at ATS 2023. #ATS2023 NIAAA News RESAT CINAR

onlinelibrary.wiley.com/doi/full/10.10… 👇🔥

Abhishek Basu presented an example why we need multi-target therapeutic approach to #curePF #cureHPS #ATS2023 with simultaneously dual-targeting #CB1R and #iNOS for inhibition by #polypharmacology👇

Exciting Monday for Cinar lab #ICRS2023Toronto with presententing ✨Role of CB1R in pulmonary fibrosis ✨Why inhalational MRI-1867 (zevaquenabant) can be an emerging anti-fibrotic in PF. ✨Endocannabinoids in lungs with alcohol drinking ✨Novel peripheral CB1 antagonists

Last day of #ICRS2023Toronto. Successful meeting with exciting science, discussions and meeting with colleagues and friends! First time attendance of many Cinar lab members (Muhammad Arif @pommerollelenny madelinebehee Natalie Johnson). All the team members give excellent presentations.

🏆Congratulations to all awardees in #ICRS2023Toronto. I am also so proud that Szabolcs Dvoracsko and Natalie Johnson Natalie Johnson are among the award recipients in post-doctoral and predoctoral categories. Proud PI 👇

Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis medrxiv.org/cgi/content/sh… #medRxiv

📣Our research @JCI_Insight highlights the key role of #cannabinoid receptor 1 (#CB1R) in #AlveolarMacrophages in promoting #PulmonaryFibrosis. We propose that pulmonary delivery of #zevaquanabant as an effective and safer therapeutic approach for PF insight.jci.org/articles/view/…

Patients with pulmonary fibrosis have limited treatment options. RESAT CINAR Abhishek Basu & team NIH Intramural NIH Intramural investigate the role of cannabinoid receptor 1 activation in alveolar macrophages and mitigate pulmonary fibrosis using an oropharyngeal treatment (MRI-1867)

Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis by RESAT CINAR Abhishek Basu et al. insight.jci.org/articles/view/…

ICYMI: Patients with pulmonary fibrosis have limited treatment options. RESAT CINAR Abhishek Basu & team NIH Intramural investigate the role of cannabinoid receptor 1 activation in alveolar macrophages and mitigate pulmonary fibrosis using an oropharyngeal treatment (MRI-1867) in a